MedBrain Global logo

MedBrain Global

Reliable diagnostic support for healthcare professionals working in low and middle-income nations.

7 employees · est. 2022 · Barcelona, Spain

VS
Syros Pharmaceuticals logo

Syros Pharmaceuticals

By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients

88 employees · est. 2012 · Cambridge, United States

Syros Pharmaceuticals is the older company (2022 vs 2012); Syros Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

MedBrain Global Syros Pharmaceuticals
Founded
2022 2012 older
Headquarters
Barcelona, Spain Cambridge, United States
Employees
7 88 larger
Industry
Health Care Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Pre Seed IPO
Total Funding
Not tracked yet $494.90M
Funding Rounds
1 11
Services
Diagnostic Support System Not tracked yet
Target Customers
Healthcare Professionals, Resource-Scarce Regions Not tracked yet
Taxonomy
AI-powered Solutions, Clinical Decision Support, Resource-scarce Healthcare, Telemedicine, Healthcare Innovation, Diagnostic Tools, Frontline Health Workers, Scalable Healthcare Models, Low-resource Healthcare, Digital Health Solutions, Patient Management, Clinical Trials Validation, Medical AI Gene Expression Control, Hematologic Malignancies, Small Molecule Therapeutics, RARα Agonist, Myelodysplastic Syndrome, RARA Gene Overexpression, Oncology, Gene Regulatory Circuits, Drug Discovery, Bioinformatics, Assay Technologies, Genomic Data Integration, Biologic Insights
Website
medbrain.io syros.com
MedBrain Global logo

About MedBrain Global

MedBrain Global, founded in 2022, has made a promising entry into the Health Care sector by providing an offline, AI-powered clinical assistant designed to support healthcare professionals in low and middle-income nations. With the slogan, "Reliable diagnostic support for healthcare professionals w...

Syros Pharmaceuticals logo

About Syros Pharmaceuticals

Syros Pharmaceuticals, founded in 2012, is a trailblazer in the Biotechnology and Pharmaceutical industries, known for its mission: "By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients". Headquartered in the United States, Syros is...

We will tell you when either one moves

BounceWatch watches MedBrain Global and Syros Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at MedBrain Global and Syros Pharmaceuticals — by email.

Frequently Asked Questions

MedBrain Global — Reliable diagnostic support for healthcare professionals working in low and middle-income nations.. Syros Pharmaceuticals — By redefining the power of small molecules to control gene expression, we aim to provide a profound benefit for patients. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
MedBrain Global has raised undisclosed funding while Syros Pharmaceuticals has raised $494.90M.
MedBrain Global and Syros Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare MedBrain Global with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at MedBrain Global on 26 Nov 2025, and Syros Pharmaceuticals on 27 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy